Moreover, the knockdown of RAD51 increased the anti-cancer activity of alpinumisoflavone in preclinical CRC models, while the alpinumisoflavone effect was abolished by the up-regulation of RAD51 [135]. Here, RAD51 is linked to colorectal carcinoma.